Literature DB >> 9694874

Complex NF-kappaB interactions at the distal tumor necrosis factor promoter region in human monocytes.

I A Udalova1, J C Knight, V Vidal, S A Nedospasov, D Kwiatkowski.   

Abstract

We describe a dense cluster of DNA-protein interactions located 600 nucleotides upstream of the transcriptional start site of the human tumor necrosis factor (TNF) gene. This area was identified as being of potential importance for lipopolysaccharide-inducible TNF expression in the human monocyte cell line Mono Mac 6, based on reporter gene analysis of point mutations at a number of nuclear factor kappaB (NF-kappaB)-like motifs within the human TNF promoter region. The area contains two NF-kappaB sites, which are here shown by DNase I and methylation interference footprinting to flank a novel binding site. UV cross-linking studies reveal that the novel site can also bind NF-kappaB as well as an unknown protein(s) of approximately 40 kDa. We show that these three adjacent kappaB-binding sites differ markedly in their relative affinities for p50/p50, p65/p65, and p65/p50, yet this 39-nucleotide segment of DNA appears capable of binding up to three NF-kappaB heterodimers simultaneously. Reporter gene studies indicate that each element of the cluster contributes to lipopolysaccharide-induced transcriptional activation in Mono Mac 6 cells. These findings suggest that NF-kappaB acts in a complex manner to activate TNF transcription in human monocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694874     DOI: 10.1074/jbc.273.33.21178

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Functional consequences of a polymorphism affecting NF-kappaB p50-p50 binding to the TNF promoter region.

Authors:  I A Udalova; A Richardson; A Denys; C Smith; H Ackerman; B Foxwell; D Kwiatkowski
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Quantitative high-throughput analysis of transcription factor binding specificities.

Authors:  Jane Linnell; Richard Mott; Simon Field; Dominic P Kwiatkowski; Jiannis Ragoussis; Irina A Udalova
Journal:  Nucleic Acids Res       Date:  2004-02-27       Impact factor: 16.971

3.  A common haplotype of the TNF receptor 2 gene modulates endotoxin tolerance.

Authors:  Benjamin P Fairfax; Emma E Davenport; Seiko Makino; Adrian V S Hill; Fredrik O Vannberg; Julian C Knight
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

4.  The role of transposable elements in the regulation of IFN-lambda1 gene expression.

Authors:  Scott J P Thomson; Fui G Goh; Helen Banks; Thomas Krausgruber; Sergei V Kotenko; Brian M J Foxwell; Irina A Udalova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

5.  In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy.

Authors:  Ling Zheng; Raja Sinniah; Stephen I-Hong Hsu
Journal:  Virchows Arch       Date:  2005-10-05       Impact factor: 4.064

Review 6.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

7.  Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis.

Authors:  E L Kaijzel; M V van Krugten; B M Brinkman; T W Huizinga; T van der Straaten; J M Hazes; H W Ziegler-Heitbrock; S A Nedospasov; F C Breedveld; C L Verweij
Journal:  Mol Med       Date:  1998-11       Impact factor: 6.354

8.  Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105.

Authors:  S Beinke; M J Robinson; M Hugunin; S C Ley
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 9.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  Identification of a novel beta-cell glucokinase (GCK) promoter mutation (-71G>C) that modulates GCK gene expression through loss of allele-specific Sp1 binding causing mild fasting hyperglycemia in humans.

Authors:  Daniela Gasperíková; Nicolas D Tribble; Juraj Staník; Miroslava Hucková; Nadezda Misovicová; Martijn van de Bunt; Lucia Valentínová; Beryl A Barrow; L'ubomir Barák; Radoslav Dobránsky; Eva Bereczková; Jozef Michálek; Kate Wicks; Kevin Colclough; Julian C Knight; Sian Ellard; Iwar Klimes; Anna L Gloyn
Journal:  Diabetes       Date:  2009-05-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.